List of Excipients in API nivolumab and hyaluronidase-nvhy
✉ Email this page to a colleague
Detailed excipient profiles for nivolumab and hyaluronidase-nvhy
Excipient focus: HISTIDINE
nivolumab and hyaluronidase-nvhy drug variants containing HISTIDINE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | nivolumab and hyaluronidase-nvhy | 0003-6120 |
| >Company | >Ingredient | >NDC |
nivolumab and hyaluronidase-nvhy drug variants not containing HISTIDINE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
nivolumab and hyaluronidase-nvhy drug variants containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | nivolumab and hyaluronidase-nvhy | 0003-6120 |
| >Company | >Ingredient | >NDC |
nivolumab and hyaluronidase-nvhy drug variants not containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: METHIONINE
nivolumab and hyaluronidase-nvhy drug variants containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | nivolumab and hyaluronidase-nvhy | 0003-6120 |
| >Company | >Ingredient | >NDC |
nivolumab and hyaluronidase-nvhy drug variants not containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: PENTETIC ACID
nivolumab and hyaluronidase-nvhy drug variants containing PENTETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | nivolumab and hyaluronidase-nvhy | 0003-6120 |
| >Company | >Ingredient | >NDC |
nivolumab and hyaluronidase-nvhy drug variants not containing PENTETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
nivolumab and hyaluronidase-nvhy drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | nivolumab and hyaluronidase-nvhy | 0003-6120 |
| >Company | >Ingredient | >NDC |
nivolumab and hyaluronidase-nvhy drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
nivolumab and hyaluronidase-nvhy drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | nivolumab and hyaluronidase-nvhy | 0003-6120 |
| >Company | >Ingredient | >NDC |
nivolumab and hyaluronidase-nvhy drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
nivolumab and hyaluronidase-nvhy drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | nivolumab and hyaluronidase-nvhy | 0003-6120 |
| >Company | >Ingredient | >NDC |
nivolumab and hyaluronidase-nvhy drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
nivolumab and hyaluronidase-nvhy drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | nivolumab and hyaluronidase-nvhy | 0003-6120 |
| >Company | >Ingredient | >NDC |
nivolumab and hyaluronidase-nvhy drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
